Biochemical markers of bone metabolism in breast cancer patients with bone metastases

Evaluation of different biochemical markers of bone turnover as a diagnostic tool for osteoporosis in postmenopausal women

Serum carboxy-terminal telopeptide of type I collagen (ICTP) as a marker of bone metastasis from lung cancer

Osteoprotegerin as a prognostic marker in patients with breast cancer

Value of bone resorption markers to predict skeletal related events and response to bisphosphonate therapy in patients with bone metastases

RANKL as a prognostic marker in patients with breast cancer

Osteoprotegerin and crosslaps, new markers of bone remodeling in postmenopausal osteoporosis

Role of new bone markers in diagnosis of renal osteodystrophy in uremic patients on hemodialysis

RANKL and osteoprotegerin gene polymorphisms and their protein levels in breast cancer patients

Plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers in the peripheral blood of breast cancer patients